Literature DB >> 10875198

The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.

S Nishijima1, I Kurokawa, N Katoh, K Watanabe.   

Abstract

We examined the species of bacteria aerobically and anaerobically isolated from 30 acne lesions and determined antimicrobial susceptibilities of Propionibacterium acnes (P. acnes) and Staphylococcus epidermidis (S. epidermidis) using nine antimicrobial agents. Among the bacteria isolated, S. epidermidis was most dominant. Both P. acnes and S. epidermidis were isolated from half of the acne lesions. The MIC of seven antimicrobials (ampicillin, erythromycin, roxithromycin, clindamycin, tetracycline, minocycline, nadifloxacin) against P. acnes was under 3.13 micrograms/ml. There were very few resistant strains of P. acnes, but many of S. epidermidis. More than 30% of the S. epidermidis isolates were resistant to erythromycin, roxithromycin, and clindamycin. After long-term systemic antibiotic therapy, the resistant strains of S. epidermidis increased, but P. acnes resistance was still limited. When we use antimicrobial agents for the treatment of acne, it should be noticed that not only P. acnes but also S. epidermidis in the acne lesions may acquire resistance to antimicrobials.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10875198     DOI: 10.1111/j.1346-8138.2000.tb02174.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  20 in total

Review 1.  Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.

Authors:  Yvonne Achermann; Ellie J C Goldstein; Tom Coenye; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 2.  Anti-infective properties of bacteriocins: an update.

Authors:  Riadh Hammami; Benoit Fernandez; Christophe Lacroix; Ismail Fliss
Journal:  Cell Mol Life Sci       Date:  2012-10-30       Impact factor: 9.261

3.  Antimicrobial susceptibility of Propionibacterium acnes isolates from shoulder surgery.

Authors:  John K Crane; Donald W Hohman; Scott R Nodzo; Thomas R Duquin
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

Review 4.  Acne, the Skin Microbiome, and Antibiotic Treatment.

Authors:  Haoxiang Xu; Huiying Li
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

Review 5.  Commercial Essential Oils as Potential Antimicrobials to Treat Skin Diseases.

Authors:  Ané Orchard; Sandy van Vuuren
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-04       Impact factor: 2.629

6.  Invasive Propionibacterium acnes infections in a non-selective patient cohort: clinical manifestations, management and outcome.

Authors:  M Tebruegge; C Jones; H de Graaf; P Sukhtankar; R N Allan; R P Howlin; D Browning; H Schuster; A Pallett; S Patel; S N Faust
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-18       Impact factor: 3.267

Review 7.  Current concepts of the pathogenesis of acne: implications for drug treatment.

Authors:  Harald Gollnick
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 8.  [Management of acne vulgaris: focus on clindamycin and zinc].

Authors:  H C Korting; C Schöllmann
Journal:  Hautarzt       Date:  2009-01       Impact factor: 0.751

Review 9.  The skin microbiome: potential for novel diagnostic and therapeutic approaches to cutaneous disease.

Authors:  Elizabeth A Grice
Journal:  Semin Cutan Med Surg       Date:  2014-06

10.  Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris.

Authors:  Yanhan Wang; Sherwin Kuo; Muya Shu; Jinghua Yu; Stephen Huang; Ashley Dai; Aimee Two; Richard L Gallo; Chun-Ming Huang
Journal:  Appl Microbiol Biotechnol       Date:  2013-11-22       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.